Neighborhood disadvantage, or living in a poorer region, was linked to significantly shorter survival time for ALS patients ...

IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical trial.

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

After more than a decade of living with her husband's ALS, columnist Kristin Neva has found the equipment to be helpful in ...

Repeated brain injury resulted in SOD1-ALS mice showing greater weight loss, an earlier tremor in the hind limbs, and ...

Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

Looking for an online ALS group? Columnist Dagmar Munn has you covered with helpful tips gleaned from years as a forums co-moderator.